Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
8.95
-0.13 (-1.43%)
At close: Sep 20, 2024, 4:00 PM
8.85
-0.10 (-1.12%)
After-hours: Sep 20, 2024, 4:33 PM EDT
Grifols Market Cap
Grifols has a market cap or net worth of $6.96 billion as of September 20, 2024. Its market cap has increased by 10.22% in one year.
Market Cap
6.96B
Enterprise Value
20.27B
1-Year Change
10.22%
Ranking
Category
Stock Price
$8.95
Market Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $6.96B, an increase of 39.24%. That is a compound annual growth rate of 2.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2024 | 6.24B | -21.45% |
| Dec 29, 2023 | 7.95B | 36.00% |
| Dec 30, 2022 | 5.84B | -24.31% |
| Dec 31, 2021 | 7.72B | -39.10% |
| Dec 31, 2020 | 12.68B | -20.82% |
| Dec 31, 2019 | 16.01B | 26.85% |
| Dec 31, 2018 | 12.62B | -19.90% |
| Dec 29, 2017 | 15.76B | 42.63% |
| Dec 30, 2016 | 11.05B | -0.80% |
| Dec 31, 2015 | 11.14B | -4.68% |
| Dec 31, 2014 | 11.69B | -0.94% |
| Dec 31, 2013 | 11.80B | 39.30% |
| Dec 31, 2012 | 8.47B | 134.45% |
| Dec 30, 2011 | 3.61B | -27.71% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.54B |
| Elanco Animal Health | 7.45B |
| Nuvalent | 7.20B |
| Acadia Healthcare Company | 7.19B |
| Glaukos | 7.14B |
| Bausch + Lomb | 7.04B |
| Jazz Pharmaceuticals | 6.87B |
| HealthEquity | 6.86B |